Detalhe da pesquisa
1.
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors.
Cancer Immunol Immunother
; 70(4): 1089-1099, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33113003
2.
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.
Eur J Cancer
; 196: 113425, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38039778
3.
Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors.
Target Oncol
; 16(2): 197-205, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33555543
4.
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study.
J Immunother Cancer
; 9(5)2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33986126